Publicaciones (37) Publicaciones de MARÍA DEL CARMEN RIVAS VÁZQUEZ

2014

  1. A unified nomenclature and amino acid numbering for human PTEN

    Science Signaling, Vol. 7, Núm. 332

2008

  1. Induction of paclitaxel resistance by the Kaposi's sarcoma-associated herpesvirus latent protein LANA2

    Journal of Virology, Vol. 82, Núm. 3, pp. 1518-1525

  2. The sequential activation of the yeast HOG and SLT2 pathways is required for cell survival to cell wall stress

    Molecular Biology of the Cell, Vol. 19, Núm. 3, pp. 1113-1124

2007

  1. Control of virus infection by tumour suppressors

    Carcinogenesis, Vol. 28, Núm. 6, pp. 1140-1144

  2. Latent protein LANA2 from Kaposi's sarcoma-associated herpesvirus interacts with 14-3-3 proteins and inhibits FOXO3a transcription factor

    Journal of Virology, Vol. 81, Núm. 3, pp. 1511-1516

  3. Novel and unexpected role for the tumor suppressor ARF in viral infection surveillance

    Future Virology, Vol. 2, Núm. 6, pp. 625-629

2006

  1. Antiviral action of the tumor suppressor ARF

    EMBO Journal, Vol. 25, Núm. 18, pp. 4284-4292

  2. Characterization of a human Bid homologue protein from Gallus gallus

    Gene, Vol. 372, Núm. 1-2, pp. 26-32

  3. Impact of protein kinase PKR in cell biology: From antiviral to antiproliferative action

    Microbiology and Molecular Biology Reviews, Vol. 70, Núm. 4, pp. 1032-1060

2005

  1. Characterization of MDGA1, a novel human glycosylphosphatidylinositol- anchored protein localized in lipid rafts

    Experimental Cell Research, Vol. 307, Núm. 1, pp. 91-99

  2. Identification of a nuclear export signal in the KSHV latent protein LANA2 mediating its export from the nucleus

    Experimental Cell Research, Vol. 311, Núm. 1, pp. 96-105

  3. Resistance to viral infection of super p53 mice

    Oncogene, Vol. 24, Núm. 18, pp. 3059-3062

2003

  1. Characterization of the bipartite nuclear localization signal of protein LANA2 from Kaposi's sarcoma-associated herpesvirus

    Biochemical Journal, Vol. 374, Núm. 2, pp. 545-550

  2. The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation

    Journal of General Virology, Vol. 84, Núm. 6, pp. 1463-1470

2001

  1. BCR-ABL and Interleukin 3 Promote Haematopoietic Cell Proliferation and Survival through Modulation of Cyclin D2 and p27Kip1 Expression

    Journal of Biological Chemistry, Vol. 276, Núm. 26, pp. 23572-23580

  2. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir

    Molecular Therapy, Vol. 3, Núm. 5, pp. 642-652

  3. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53

    Journal of Virology, Vol. 75, Núm. 1, pp. 429-438

2000

  1. Absence of in vitro or in vivo bystander effects in a thymidine kinase- transduced murine T lymphoma

    Cancer Gene Therapy, Vol. 7, Núm. 6, pp. 954-962

  2. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27(kip)1

    Journal of Biological Chemistry, Vol. 275, Núm. 29, pp. 21960-21968

1999

  1. Full activation of RNaseL in animal cells requires binding of 2-5A within ankyrin repeats 6 to 9 of this interferon-inducible enzyme

    Journal of Interferon and Cytokine Research, Vol. 19, Núm. 2, pp. 113-119